Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
DMD
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval for Sarepta Therapeutics’ golodirsen (Vyondys 53), an injection for patients with Duchenne muscular dystrophy (DMD) with a…
Potential new targeted therapy for Duchenne muscular dystrophy
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval for Sarepta Therapeutics’ golodirsen (Vyondys 53), an injection for patients with Duchenne muscular…